Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy.
Barratt J, Barbour S, Brenner R, Cooper K, Wei X, Eren N, Floege J, Jha V, Kim SG, Maes B, Phoon RKS, Singh H, Tesař V, Lafayette R; ORIGIN Phase 2b Investigators.
Barratt J, et al. Among authors: wei x.
J Am Soc Nephrol. 2024 Oct 26. doi: 10.1681/ASN.0000000541. Online ahead of print.
J Am Soc Nephrol. 2024.
PMID: 39462308
No abstract available.